Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EM
Embecta Corp. Common Stock
EMBC
Mkt Cap
$356.1M
Volume
509.48K
Next Earnings
November 24th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EM
EMBC
EM
Embecta Corp. Common Stock
EMBC
News
·
EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
Mkt Cap
$355.3M
Volume
509.48K
Next Earnings
November 24th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
Law firm Bernstein Liebhard announced an investigation into potential breaches of fiduciary duty by directors and officers of Embecta Corp. The firm is seeking to determine whether company leadership fulfilled its obligations to shareholders. Current shareholders who purchased shares before November 25, 2025 are encouraged to contact the firm regarding their legal rights.
GlobeNewswire Inc. · Sep 22, 2026
embecta to Participate in Investor Events
Embecta Corp. (EMBC) announced that management will participate in investor events at the Wells Fargo 2026 Healthcare Conference on September 9, 2026, in Boston and the J.P. Morgan 4th Annual Nashville Healthcare Conference 2026 on September 10, 2026, where they will host fireside chats and one-on-one investor meetings.
GlobeNewswire Inc. · Aug 31, 2026
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) for alleged violations of securities laws. The lawsuit claims the company made false and misleading statements regarding its fiscal guidance for Q2 and full-year 2026, failing to disclose known market headwinds in the pen needle sector. The class period runs from November 25, 2025 to May 4, 2026, with a deadline of August 17, 2026 for investors to participate.
GlobeNewswire Inc. · Aug 10, 2026
ZILLOW DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Zillow Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - Z, ZG
Rosen Law Firm is reminding investors in Zillow Group, Embecta Corp, and GoDaddy Inc. of upcoming lead plaintiff deadlines in securities class actions. The Zillow lawsuit alleges the company made false statements regarding its Redfin agreement and antitrust risks. Investors with losses exceeding $100K are encouraged to contact the firm before the respective deadlines.
GlobeNewswire Inc. · Aug 7, 2026
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
Embecta Corp. (NASDAQ: EMBC), a global medical supplies company with a 100-year legacy in insulin delivery, announced its third quarter fiscal 2026 financial results on August 7, 2026. The company hosted a conference call and webcast for analysts and investors to discuss the earnings.
GlobeNewswire Inc. · Aug 7, 2026
embecta Announces Quarterly Cash Dividend
Embecta Corp. (EMBC) declared a quarterly cash dividend of $0.01 per share payable on September 15, 2026. The company also announced the appointment of Nimish Muzumdar as Senior Vice President and President of North America, effective June 15, 2026.
GlobeNewswire Inc. · Aug 7, 2026
EMBC 12-DAY DEADLINE ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Hagens Berman
Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for allegedly misleading investors about the stability of its insulin pen needle business. The company claimed its pen needle portfolio was 'stable' and 'resilient' while experiencing significant competitive share loss and market volume softness. On May 5, 2026, Embecta revealed massive revenue declines, slashed full-year 2026 adjusted EPS guidance by 43%, and cut its quarterly dividend by 93%, causing the stock to plummet 57.8% in a single trading day. Investors with substantial losses during the class period (Nov. 25, 2025 – May 4, 2026) are encouraged to participate in the lawsuit with a lead plaintiff deadline of August 17, 2026.
GlobeNewswire Inc. · Aug 6, 2026
DEADLINE ALERT for ERAS, VIA, EMBC, Z: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Class action lawsuits have been filed against four publicly-traded companies alleging securities fraud. Erasca faces allegations regarding misleading preclinical data comparisons; Via Transportation failed to disclose declining ARR and regulatory issues; Embecta misrepresented guidance and segment weakness; and Zillow mischaracterized its Redfin agreement and downplayed antitrust risks. Investors have until mid-August 2026 to file lead plaintiff motions.
GlobeNewswire Inc. · Aug 5, 2026
EMBC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Embecta Corp. Securities Lawsuit - Contact SueWallSt
Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit for allegedly misleading investors about fiscal year 2026 performance. The company promised flat-to-down-2% revenue and $2.80-$3.00 EPS but delivered a 17.4% revenue collapse and slashed earnings guidance by nearly half. The stock plummeted 57.8% on May 5, 2026, from $9.25 to $3.90. The lawsuit alleges management knew of U.S. market weakness when reaffirming guidance between November 25, 2025 and February 5, 2026.
GlobeNewswire Inc. · Aug 4, 2026
EMBC 2-WEEK DEADLINE ALERT: Hagens Berman Investigates Alleged Securities Law Violations at Embecta Corp. (NASDAQ: EMBC) Following Pending Class Action Litigation
Hagens Berman is investigating Embecta Corp. for alleged securities law violations, claiming the company misrepresented the stability of its insulin pen needle business. On May 5, 2026, Embecta revealed significant revenue decline, slashed full-year EPS guidance by 43%, and cut its quarterly dividend by 93%, causing the stock to plummet 57.8% in a single trading day. The class action lawsuit covers the period from November 25, 2025 to May 4, 2026, with a lead plaintiff deadline of August 17, 2026.
GlobeNewswire Inc. · Aug 3, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
EM
EMBC
Embecta Corp. Common Stock
Buy
Sell
Market
Limit
Soon
EMBC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any EMBC yet.
Related Tickers
Earnings
Dividends
Last · Aug 27
Quarterly
Amount
$0.0100
Yield
5.09%
Annual
$0.32